HALLI FLANNAGIN: Open Payments
NPI 1215598511 · FALKVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,837 in 94 payments from 11 companies in 2025. Trend: 2023 $2,847 · 2024 $1,891 · 2025 $1,837
Food & beverage: $1,837
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $383 |
| ABBVIE INC. | 12 | $381 |
| AstraZeneca Pharmaceuticals LP | 2 | $230 |
| Antares Pharma, Inc. | 14 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $196 |
| Amgen Inc. | 10 | $171 |
| Corium, LLC | 11 | $100 |
| Vanda Pharmaceuticals Inc. | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 4 | $52 |
| Corcept Therapeutics | 3 | $48 |
Products named: VRAYLAR, Wegovy, FARXIGA, CAPLYTA, XYOSTED, OTEZLA, Azstarys, Ozempic.
Industry payments across AL — which companies pay providers there.
